-
In This Issue: Baxter Bioscience has developed a whole-virus, two dose
vaccine against avian flu; warning label now on antipsychotics regarding an increased risk of mortality in elderly patients treated for dementia-related psychosis; vitamin D for men with heart disease on
horizon? A new oral anticoagulant may soon be available for prevention of thrombotic complications of hip or knee surgery; FDA Actions
-
-
Reduction of treatment-related toxicities have direct bearing on the decision when to initiate antiretroviral therapy. Clinicians may opt to delay antiretroviral therapy or avoid certain agents because of quality-of-life issues and the risk of treatment-related toxicity.
-
Over the past several years, Japan has been the chief source of measles importation into the United States. A total of 63 cases of measles were imported to the United States from Japan during the past 22 years.
-
This active, population-based, surveillance study was conducted by the CDC, in collaboration with state health departments and universities in 10 states participating in the Active Bacterial Core Surveillance (ABCs)/Emerging Infections Program Network.
-
-
By 1998, community-acquired (ca) cases appeared among young children and are now widely documented, representing 15%-74% of Staphylococcus aureus skin and soft-tissue infections in US emergency departments.
-
Recently, authors from the University of Wisconsin Medical School asked what is the risk of infection associated with nasal colonization with Staphylococcus aureus.
-
After skin cancer, prostate cancer (P-CA) is the most common cancer among American men. Despite the absence of major consensus group endorsement, androgen deprivation therapy (ADT) has been sufficiently popular that in a 2003 report, ADT was employed second only to surgery for localized disease.
-
The combination of the first direct renin inhibitor and hydrochlorothiazide was approved by the FDA this year for the treatment of hypertension.